This NDC is on FDA's drug shortage list (posted Jul 14, 2023)
Reported reason: Shortage of an active ingredient
Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $2.6640 per EA under NDC 43547060410. Its NADAC has been published 152 times since Sep 27, 2023.
FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547060410
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216266FDA Approved
8/25/2023
TE Code
AB
On Market Since
8/26/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 152 times since Sep 27, 2023, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6640 per EA |
|---|---|
| All-time high | $6.5077 (Apr 10, 2024) |
| All-time low | $2.6640 (Aug 19, 2026) |
| 52-week high | $3.6233 |
| 52-week low | $2.6640 |
| Median price | $3.9018 |
| Average price | $4.0971 |
| Largest weekly change | +59.1% (Jun 19, 2024) |
| Weeks tracked | 152 |
| Tracking since | Sep 27, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine dimesylate capsules market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $2.6640 per EA (NDC 43547060410), effective Aug 19, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 25.2%. It has been tracked across 152 weekly CMS publications since Sep 27, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Sep 27, 2023, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.6640 (Aug 19, 2026) to a high of $6.5077 (Apr 10, 2024), with a median of $3.9018 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 43547060410) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is LISDEXAMFETAMINE 30 MG CAPSULE in shortage?
Yes — NDC 43547060410 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.